What aspirin dose is used for stroke?
For most people with suspected or confirmed ischemic stroke, aspirin is used as an antiplatelet to reduce the risk of further clot-related events. Common dosing regimens in clinical practice are:
- 160–325 mg to start, chewed as soon as stroke is suspected (or within the early treatment window used by the treating team).
- After that, ongoing maintenance is often 81–100 mg once daily, depending on the patient and local guideline.
What dose is used for TIA (mini-stroke)?
For a transient ischemic attack (TIA), aspirin dosing follows similar antiplatelet principles used for ischemic stroke: an initial dose of 160–325 mg (chewed) is often used, followed by a lower maintenance dose such as 81–100 mg daily.
Is the aspirin dose different in hemorrhagic stroke?
Yes. Aspirin can worsen bleeding, so the dose approach changes if hemorrhagic stroke is suspected or confirmed. In those situations, clinicians generally avoid giving antiplatelet dosing until imaging rules out bleeding and a specialist confirms the plan.
How does aspirin fit with dual antiplatelet therapy?
Some patients with high-risk TIA or minor ischemic stroke may be treated with dual antiplatelet therapy (aspirin plus another antiplatelet) for a limited period rather than aspirin alone. The exact dose and duration depend on the specific protocol and the patient’s bleeding risk.
Important safety notes
Aspirin dosing for stroke is time-sensitive and depends on whether clinicians think the event is ischemic (clot) versus hemorrhagic (bleed), as well as patient factors like bleeding risk, prior GI bleeding, and concurrent blood thinners.
If you tell me whether you mean suspected stroke, confirmed ischemic stroke, TIA, or hemorrhagic stroke—and the patient’s age and any blood thinner use—I can narrow the dose range to the most relevant regimen.